GGrantIndex
Sort

50,496 grants matching lung cancer

HER3-PHF8 signaling axis in triple-negative breast cancer progression

$416,723
Bolin Liu · Lsu Health Sciences Center · R01 · FY2023 · CA

IP-10 Chemokine: Role in T Cell Recruitment and Disease

$416,709
Massachusetts General Hospital · R01 · FY2004 · CA

Toward precision radiotherapy: Physiological modeling of respiratory motion based on ultra-quality 4D-MRI

$416,692
G. Wilson Miller · University Of Virginia · R01 · FY2023 · CA

Effect of Prone Position on Ventilator-Induced Lung Injury

$416,668
Guido Musch · Massachusetts General Hospital · R01 · FY2013 · HL

Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)

$416,579
Leonidas Bleris · University Of Texas Dallas · R01 · FY2025 · CA

Intracellular nucleic acid sensing and age-related chronic inflammation

$416,548
Shruti Sharma · Tufts University Boston · R01 · FY2022 · AI

Intracellular nucleic acid sensing and age-related chronic inflammation

$416,548
Shruti Sharma · Tufts University Boston · R01 · FY2023 · AI

HIV-Associated Malignancies (HIVAM)

$416,543
King Kennard Holmes · University Of Washington · P30 · FY2015 · AI

Comput. Struct.-Based Design, Chem. Synth., Biochem Charac. and Molec. Mechanism

$416,541
Shaomeng Wang · University Of Michigan At Ann Arbor · U19 · FY2009 · CA

Kisspeptins in the Airway

$416,539
Sathish Venkatachalem · North Dakota State University · R01 · FY2021 · HL

HIFU-enhanced tumor vaccines

$416,537
Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2011 · EB

Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis

$416,514
Ann Marie Pendergast · Duke University · R01 · FY2025 · CA

Benefits and Harms of Lung Cancer Screening in HIV Infection

$416,472
Kristina Anne Crothers · University Of Washington · R01 · FY2017 · CA

Role of CEACAM1 in Epithelial Cell Polarization

$416,403
John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2009 · CA

Appraisal Delay and Disparities in Timely Cancer Diagnosis

$416,402
Laura A Siminoff · Virginia Commonwealth University · R01 · FY2008 · CA

Prevalence effects in visual search: Theoretical and practical implications

$416,284
Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2015 · EY

Tumor Suppressor Qualities and Mechanisms of LZAP Activity

$416,250
Wendell G Yarbrough · Yale University · R01 · FY2014 · DE

NEUROLOGICAL PARANEOPLASTIC SYNDROMES

$416,250
Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · NS

Tumor Suppressor Qualities and Mechanisms of LZAP Activity

$416,250
Wendell G Yarbrough · Yale University · R01 · FY2015 · DE

NEUROLOGICAL PARANEOPLASTIC SYNDROMES

$416,250
Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · NS

NEUROLOGICAL PARANEOPLASTIC SYNDROMES

$416,250
Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · NS

Tumor Suppressor Qualities and Mechanisms of LZAP Activity

$416,250
Wendell G Yarbrough · Yale University · R01 · FY2016 · DE

Targeting TREM2 to boost anti-cancer therapy

$416,242
Marco Colonna · Washington University · R01 · FY2021 · CA

Role of Formylpeptide Receptors in Host Defense

$416,215
Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Molecular Mechanisms of Cachexia in Lung Cancer

$416,213
Carlo M Croce · Ohio State University · R01 · FY2019 · CA